Structure

Physi-Chem Properties

Molecular Weight:  404.18
Volume:  415.032
LogP:  4.079
LogD:  3.241
LogS:  -4.715
# Rotatable Bonds:  12
TPSA:  92.04
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.441
Synthetic Accessibility Score:  3.127
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.681
MDCK Permeability:  7.051265856716782e-05
Pgp-inhibitor:  0.952
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.938

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.909
Plasma Protein Binding (PPB):  91.5323257446289%
Volume Distribution (VD):  0.461
Pgp-substrate:  10.00171184539795%

ADMET: Metabolism

CYP1A2-inhibitor:  0.915
CYP1A2-substrate:  0.837
CYP2C19-inhibitor:  0.936
CYP2C19-substrate:  0.402
CYP2C9-inhibitor:  0.931
CYP2C9-substrate:  0.917
CYP2D6-inhibitor:  0.16
CYP2D6-substrate:  0.733
CYP3A4-inhibitor:  0.831
CYP3A4-substrate:  0.334

ADMET: Excretion

Clearance (CL):  3.423
Half-life (T1/2):  0.716

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.65
Drug-inuced Liver Injury (DILI):  0.867
AMES Toxicity:  0.199
Rat Oral Acute Toxicity:  0.543
Maximum Recommended Daily Dose:  0.795
Skin Sensitization:  0.824
Carcinogencity:  0.061
Eye Corrosion:  0.005
Eye Irritation:  0.076
Respiratory Toxicity:  0.071

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471640

Natural Product ID:  NPC471640
Common Name*:   Methyl 2-[2-[(6R)-6-Acetyloxyheptyl]-7-Methoxy-4-Oxochromen-5-Yl]Acetate
IUPAC Name:   methyl 2-[2-[(6R)-6-acetyloxyheptyl]-7-methoxy-4-oxochromen-5-yl]acetate
Synonyms:  
Standard InCHIKey:  LIDOJFNNQVPBFX-CQSZACIVSA-N
Standard InCHI:  InChI=1S/C22H28O7/c1-14(28-15(2)23)8-6-5-7-9-17-12-19(24)22-16(11-21(25)27-4)10-18(26-3)13-20(22)29-17/h10,12-14H,5-9,11H2,1-4H3/t14-/m1/s1
SMILES:  COC(=O)Cc1cc(OC)cc2c1c(=O)cc(o2)CCCCC[C@H](OC(=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3086813
PubChem CID:   72946055
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0000144] Chromones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33175 Pestalotiopsis sp. Species Sporocadaceae Eukaryota n.a. n.a. n.a. PMID[19117486]
NPO33175 Pestalotiopsis sp. Species Sporocadaceae Eukaryota chinese mangrove plant Rhizophora mucronata n.a. n.a. PMID[19271764]
NPO33175 Pestalotiopsis sp. Species Sporocadaceae Eukaryota Chinese mangrove plant Rhizophoramucronata n.a. n.a. PMID[19762244]
NPO33175 Pestalotiopsis sp. Species Sporocadaceae Eukaryota Isolated from the branches of Podocarpus macrophyllus Kunming World Horticultural Exposition Garden, Kunming, China 2002-NOV PMID[21302965]
NPO33175 Pestalotiopsis sp. Species Sporocadaceae Eukaryota n.a. n.a. n.a. PMID[24168147]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT19 Organism Escherichia coli Escherichia coli MIC > 500.0 ug.mL-1 PMID[509449]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 500.0 ug.mL-1 PMID[509449]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis MIC > 500.0 ug.mL-1 PMID[509449]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC > 500.0 ug.mL-1 PMID[509449]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471640 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC471644
0.9781 High Similarity NPC471643
0.9781 High Similarity NPC471639
0.9574 High Similarity NPC471641
0.9574 High Similarity NPC471642
0.9574 High Similarity NPC240253
0.9574 High Similarity NPC240622
0.95 High Similarity NPC312789
0.9225 High Similarity NPC472034
0.9161 High Similarity NPC472033
0.9155 High Similarity NPC184702
0.9149 High Similarity NPC297985
0.9149 High Similarity NPC469579
0.9097 High Similarity NPC472036
0.9085 High Similarity NPC472006
0.9085 High Similarity NPC478202
0.9078 High Similarity NPC1704
0.9078 High Similarity NPC67650
0.9071 High Similarity NPC57380
0.9041 High Similarity NPC60413
0.9028 High Similarity NPC473927
0.9021 High Similarity NPC95123
0.9021 High Similarity NPC470932
0.9021 High Similarity NPC66404
0.9014 High Similarity NPC474385
0.8973 High Similarity NPC6923
0.8963 High Similarity NPC473907
0.8958 High Similarity NPC134621
0.8951 High Similarity NPC215451
0.8951 High Similarity NPC469542
0.8951 High Similarity NPC51106
0.8951 High Similarity NPC277369
0.8944 High Similarity NPC478201
0.8944 High Similarity NPC158634
0.8944 High Similarity NPC478217
0.8944 High Similarity NPC475730
0.8944 High Similarity NPC472035
0.8944 High Similarity NPC313123
0.8936 High Similarity NPC32360
0.8936 High Similarity NPC92655
0.8936 High Similarity NPC268052
0.8929 High Similarity NPC135837
0.8929 High Similarity NPC268081
0.8904 High Similarity NPC153417
0.8897 High Similarity NPC107625
0.8897 High Similarity NPC237208
0.8897 High Similarity NPC473894
0.8889 High Similarity NPC280404
0.8889 High Similarity NPC475496
0.8889 High Similarity NPC189650
0.8889 High Similarity NPC86373
0.8889 High Similarity NPC277426
0.8889 High Similarity NPC210425
0.8889 High Similarity NPC49852
0.8881 High Similarity NPC105648
0.8873 High Similarity NPC136095
0.8873 High Similarity NPC109007
0.8865 High Similarity NPC191835
0.8865 High Similarity NPC253616
0.8865 High Similarity NPC478200
0.8865 High Similarity NPC33144
0.8857 High Similarity NPC242712
0.8851 High Similarity NPC473732
0.8836 High Similarity NPC210320
0.8836 High Similarity NPC52106
0.8832 High Similarity NPC473271
0.8828 High Similarity NPC473692
0.8828 High Similarity NPC171656
0.8828 High Similarity NPC29577
0.8828 High Similarity NPC294365
0.8811 High Similarity NPC307990
0.8811 High Similarity NPC220106
0.8811 High Similarity NPC16455
0.8803 High Similarity NPC36414
0.8794 High Similarity NPC65837
0.8794 High Similarity NPC474771
0.8794 High Similarity NPC70380
0.8794 High Similarity NPC178467
0.8794 High Similarity NPC149372
0.8794 High Similarity NPC254741
0.8794 High Similarity NPC474849
0.8792 High Similarity NPC475116
0.8786 High Similarity NPC470844
0.8786 High Similarity NPC180905
0.8786 High Similarity NPC182496
0.8784 High Similarity NPC295036
0.8784 High Similarity NPC158866
0.8784 High Similarity NPC474660
0.8777 High Similarity NPC473655
0.8777 High Similarity NPC101294
0.8776 High Similarity NPC37139
0.8776 High Similarity NPC73411
0.8776 High Similarity NPC215711
0.8759 High Similarity NPC210966
0.8759 High Similarity NPC478203
0.8759 High Similarity NPC27106
0.8759 High Similarity NPC126882
0.875 High Similarity NPC250755
0.875 High Similarity NPC96692
0.8742 High Similarity NPC474983
0.8741 High Similarity NPC472515
0.8732 High Similarity NPC472602
0.8732 High Similarity NPC103001
0.8732 High Similarity NPC94248
0.8732 High Similarity NPC475974
0.8732 High Similarity NPC472403
0.8732 High Similarity NPC9121
0.8732 High Similarity NPC212693
0.8732 High Similarity NPC177307
0.8725 High Similarity NPC133856
0.8723 High Similarity NPC99854
0.8723 High Similarity NPC235115
0.8716 High Similarity NPC473978
0.8716 High Similarity NPC233267
0.8716 High Similarity NPC291049
0.8716 High Similarity NPC476684
0.8714 High Similarity NPC175943
0.8707 High Similarity NPC14098
0.8707 High Similarity NPC259632
0.8707 High Similarity NPC12305
0.8705 High Similarity NPC278556
0.8699 High Similarity NPC257558
0.869 High Similarity NPC310340
0.8681 High Similarity NPC53649
0.8681 High Similarity NPC470856
0.8681 High Similarity NPC472603
0.8681 High Similarity NPC90411
0.8676 High Similarity NPC101894
0.8675 High Similarity NPC89625
0.8675 High Similarity NPC149618
0.8667 High Similarity NPC273483
0.8658 High Similarity NPC475460
0.8658 High Similarity NPC473466
0.8652 High Similarity NPC125269
0.8652 High Similarity NPC298900
0.8649 High Similarity NPC105415
0.8643 High Similarity NPC153783
0.8643 High Similarity NPC10971
0.8643 High Similarity NPC203817
0.8639 High Similarity NPC267509
0.8621 High Similarity NPC24075
0.8621 High Similarity NPC29536
0.8621 High Similarity NPC22467
0.8611 High Similarity NPC472601
0.8611 High Similarity NPC473209
0.8611 High Similarity NPC139554
0.8611 High Similarity NPC158472
0.8611 High Similarity NPC472600
0.8609 High Similarity NPC472799
0.8601 High Similarity NPC259685
0.86 High Similarity NPC215921
0.86 High Similarity NPC72958
0.86 High Similarity NPC70016
0.86 High Similarity NPC232645
0.8592 High Similarity NPC46869
0.8591 High Similarity NPC97028
0.8591 High Similarity NPC237440
0.8591 High Similarity NPC288036
0.8591 High Similarity NPC164299
0.8591 High Similarity NPC4423
0.8591 High Similarity NPC65589
0.8591 High Similarity NPC158338
0.8591 High Similarity NPC97029
0.8591 High Similarity NPC77325
0.8591 High Similarity NPC100985
0.8591 High Similarity NPC270160
0.8582 High Similarity NPC223354
0.8582 High Similarity NPC292998
0.8582 High Similarity NPC247743
0.8582 High Similarity NPC223457
0.8571 High Similarity NPC475589
0.8571 High Similarity NPC32470
0.8571 High Similarity NPC471590
0.8571 High Similarity NPC31872
0.8571 High Similarity NPC473584
0.8571 High Similarity NPC284424
0.8562 High Similarity NPC70853
0.8562 High Similarity NPC112829
0.8562 High Similarity NPC159721
0.8562 High Similarity NPC246466
0.8562 High Similarity NPC294432
0.8562 High Similarity NPC73028
0.8562 High Similarity NPC263483
0.8562 High Similarity NPC9966
0.8562 High Similarity NPC470556
0.8552 High Similarity NPC171094
0.8552 High Similarity NPC472605
0.8552 High Similarity NPC244923
0.8552 High Similarity NPC472604
0.8552 High Similarity NPC275734
0.8552 High Similarity NPC474037
0.8543 High Similarity NPC271681
0.8543 High Similarity NPC474843
0.8543 High Similarity NPC87708
0.8542 High Similarity NPC247409
0.8542 High Similarity NPC105456
0.8542 High Similarity NPC131130
0.8542 High Similarity NPC474655
0.8542 High Similarity NPC139634
0.8535 High Similarity NPC472895

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471640 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8936 High Similarity NPD970 Clinical (unspecified phase)
0.8794 High Similarity NPD2796 Approved
0.8733 High Similarity NPD7819 Suspended
0.8503 High Similarity NPD6799 Approved
0.8462 Intermediate Similarity NPD3748 Approved
0.8431 Intermediate Similarity NPD3817 Phase 2
0.8356 Intermediate Similarity NPD1243 Approved
0.8355 Intermediate Similarity NPD7411 Suspended
0.8322 Intermediate Similarity NPD2533 Approved
0.8322 Intermediate Similarity NPD2534 Approved
0.8322 Intermediate Similarity NPD2532 Approved
0.8289 Intermediate Similarity NPD6599 Discontinued
0.8247 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8219 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8219 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8212 Intermediate Similarity NPD920 Approved
0.82 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD6801 Discontinued
0.8176 Intermediate Similarity NPD3750 Approved
0.8169 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8163 Intermediate Similarity NPD1549 Phase 2
0.8129 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8089 Intermediate Similarity NPD7075 Discontinued
0.8082 Intermediate Similarity NPD1510 Phase 2
0.8079 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8065 Intermediate Similarity NPD1934 Approved
0.805 Intermediate Similarity NPD6959 Discontinued
0.8038 Intermediate Similarity NPD919 Approved
0.8028 Intermediate Similarity NPD6832 Phase 2
0.8013 Intermediate Similarity NPD1511 Approved
0.8013 Intermediate Similarity NPD2801 Approved
0.8012 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD5494 Approved
0.7974 Intermediate Similarity NPD5403 Approved
0.7962 Intermediate Similarity NPD5402 Approved
0.7961 Intermediate Similarity NPD5401 Approved
0.7933 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD1240 Approved
0.7911 Intermediate Similarity NPD3882 Suspended
0.7908 Intermediate Similarity NPD1512 Approved
0.7905 Intermediate Similarity NPD1551 Phase 2
0.7877 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD3226 Approved
0.7862 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD3749 Approved
0.7843 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD1247 Approved
0.7823 Intermediate Similarity NPD1607 Approved
0.7821 Intermediate Similarity NPD4380 Phase 2
0.7817 Intermediate Similarity NPD3267 Approved
0.7817 Intermediate Similarity NPD3266 Approved
0.7799 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD7768 Phase 2
0.7778 Intermediate Similarity NPD6232 Discontinued
0.7758 Intermediate Similarity NPD5844 Phase 1
0.7758 Intermediate Similarity NPD7054 Approved
0.7748 Intermediate Similarity NPD2654 Approved
0.7748 Intermediate Similarity NPD2800 Approved
0.7744 Intermediate Similarity NPD7473 Discontinued
0.7718 Intermediate Similarity NPD2799 Discontinued
0.7711 Intermediate Similarity NPD7472 Approved
0.7697 Intermediate Similarity NPD3818 Discontinued
0.7697 Intermediate Similarity NPD4628 Phase 3
0.7683 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD6166 Phase 2
0.7683 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7671 Intermediate Similarity NPD3268 Approved
0.7671 Intermediate Similarity NPD1296 Phase 2
0.7669 Intermediate Similarity NPD5710 Approved
0.7669 Intermediate Similarity NPD5711 Approved
0.7667 Intermediate Similarity NPD2935 Discontinued
0.7665 Intermediate Similarity NPD6797 Phase 2
0.7643 Intermediate Similarity NPD17 Approved
0.7639 Intermediate Similarity NPD1019 Discontinued
0.7628 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD3926 Phase 2
0.7619 Intermediate Similarity NPD7251 Discontinued
0.7616 Intermediate Similarity NPD2346 Discontinued
0.7606 Intermediate Similarity NPD9717 Approved
0.7605 Intermediate Similarity NPD7074 Phase 3
0.7582 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7808 Phase 3
0.755 Intermediate Similarity NPD6099 Approved
0.755 Intermediate Similarity NPD6100 Approved
0.7545 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD422 Phase 1
0.7517 Intermediate Similarity NPD230 Phase 1
0.75 Intermediate Similarity NPD1471 Phase 3
0.7485 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD7033 Discontinued
0.7483 Intermediate Similarity NPD1608 Approved
0.747 Intermediate Similarity NPD2403 Approved
0.7467 Intermediate Similarity NPD6651 Approved
0.7456 Intermediate Similarity NPD5953 Discontinued
0.7455 Intermediate Similarity NPD6808 Phase 2
0.7453 Intermediate Similarity NPD1465 Phase 2
0.7448 Intermediate Similarity NPD1203 Approved
0.7447 Intermediate Similarity NPD5691 Approved
0.7432 Intermediate Similarity NPD411 Approved
0.7432 Intermediate Similarity NPD2313 Discontinued
0.7415 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD6559 Discontinued
0.7407 Intermediate Similarity NPD5353 Approved
0.7407 Intermediate Similarity NPD4288 Approved
0.74 Intermediate Similarity NPD1933 Approved
0.74 Intermediate Similarity NPD447 Suspended
0.7397 Intermediate Similarity NPD2798 Approved
0.7394 Intermediate Similarity NPD7199 Phase 2
0.7391 Intermediate Similarity NPD1241 Discontinued
0.7389 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD7229 Phase 3
0.7337 Intermediate Similarity NPD7286 Phase 2
0.7333 Intermediate Similarity NPD4307 Phase 2
0.7329 Intermediate Similarity NPD5889 Approved
0.7329 Intermediate Similarity NPD5890 Approved
0.7329 Intermediate Similarity NPD2797 Approved
0.7315 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD5124 Phase 1
0.7285 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD2344 Approved
0.7273 Intermediate Similarity NPD1778 Approved
0.7273 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD3225 Approved
0.7254 Intermediate Similarity NPD9545 Approved
0.7246 Intermediate Similarity NPD3787 Discontinued
0.7241 Intermediate Similarity NPD3972 Approved
0.7233 Intermediate Similarity NPD6273 Approved
0.7219 Intermediate Similarity NPD2979 Phase 3
0.7215 Intermediate Similarity NPD7390 Discontinued
0.7208 Intermediate Similarity NPD2438 Suspended
0.7202 Intermediate Similarity NPD5242 Approved
0.7197 Intermediate Similarity NPD3887 Approved
0.7179 Intermediate Similarity NPD1652 Phase 2
0.7178 Intermediate Similarity NPD37 Approved
0.7176 Intermediate Similarity NPD3751 Discontinued
0.7172 Intermediate Similarity NPD1281 Approved
0.7171 Intermediate Similarity NPD6355 Discontinued
0.716 Intermediate Similarity NPD6585 Discontinued
0.7153 Intermediate Similarity NPD4626 Approved
0.7152 Intermediate Similarity NPD4965 Approved
0.7152 Intermediate Similarity NPD8032 Phase 2
0.7152 Intermediate Similarity NPD4966 Approved
0.7152 Intermediate Similarity NPD4967 Phase 2
0.7143 Intermediate Similarity NPD1876 Approved
0.7143 Intermediate Similarity NPD4308 Phase 3
0.7143 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD9493 Approved
0.7105 Intermediate Similarity NPD3140 Approved
0.7105 Intermediate Similarity NPD943 Approved
0.7105 Intermediate Similarity NPD3142 Approved
0.7103 Intermediate Similarity NPD3496 Discontinued
0.7097 Intermediate Similarity NPD4476 Approved
0.7097 Intermediate Similarity NPD4477 Approved
0.7089 Intermediate Similarity NPD2309 Approved
0.7088 Intermediate Similarity NPD8285 Discontinued
0.7086 Intermediate Similarity NPD6798 Discontinued
0.7083 Intermediate Similarity NPD1651 Approved
0.7083 Intermediate Similarity NPD5585 Approved
0.7067 Intermediate Similarity NPD4908 Phase 1
0.7066 Intermediate Similarity NPD6234 Discontinued
0.7049 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD6652 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD8313 Approved
0.7029 Intermediate Similarity NPD8312 Approved
0.7027 Intermediate Similarity NPD1283 Approved
0.7014 Intermediate Similarity NPD1548 Phase 1
0.7012 Intermediate Similarity NPD6385 Approved
0.7012 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6386 Approved
0.7006 Intermediate Similarity NPD8434 Phase 2
0.7006 Intermediate Similarity NPD6971 Discontinued
0.7 Intermediate Similarity NPD7837 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.6993 Remote Similarity NPD4060 Phase 1
0.6987 Remote Similarity NPD5404 Approved
0.6987 Remote Similarity NPD5405 Approved
0.6987 Remote Similarity NPD2531 Phase 2
0.6987 Remote Similarity NPD5406 Approved
0.6987 Remote Similarity NPD5408 Approved
0.6978 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6977 Remote Similarity NPD7177 Discontinued
0.6974 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6974 Remote Similarity NPD3764 Approved
0.697 Remote Similarity NPD6279 Approved
0.697 Remote Similarity NPD6844 Discontinued
0.697 Remote Similarity NPD6280 Approved
0.6961 Remote Similarity NPD4360 Phase 2
0.6961 Remote Similarity NPD4363 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data